Cochrane Abstracts
Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus Edited (no change to conclusions)
Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Furosemide for Prevention of Morbidity in Indomethacin‐treated Infants With Patent Ductus Arteriosus Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434392/all/Furosemide_for_prevention_of_morbidity_in_indomethacin_treated_infants_with_patent_ductus_arteriosus:_Cochrane_systematic_review. Accessed 11 August 2020.
Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434392/all/Furosemide_for_prevention_of_morbidity_in_indomethacin_treated_infants_with_patent_ductus_arteriosus:_Cochrane_systematic_review. Accessed August 11, 2020.
Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus Edited (no change to conclusions). In Cochrane Abstracts Retrieved August 11, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/434392/all/Furosemide_for_prevention_of_morbidity_in_indomethacin_treated_infants_with_patent_ductus_arteriosus:_Cochrane_systematic_review
Furosemide for Prevention of Morbidity in Indomethacin‐treated Infants With Patent Ductus Arteriosus Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2020 August 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434392/all/Furosemide_for_prevention_of_morbidity_in_indomethacin_treated_infants_with_patent_ductus_arteriosus:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus Edited (no change to conclusions)
ID - 434392
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434392/all/Furosemide_for_prevention_of_morbidity_in_indomethacin_treated_infants_with_patent_ductus_arteriosus:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
